Table 3.
Continuous glucose monitoring data (CGM) only in the compliant CPAP users, defined as a minimum usage of 4 h per night for at least 70% of all nights
| Only compliant CPAP users |
CPAP/baseline n = 16 |
CPAP/12 wk n = 16 |
CPAP group change n = 16 |
P‐value paired t test | Between group difference a CPAP n = 16 control = 29 | P‐value |
|---|---|---|---|---|---|---|
| Time with CGM‐ data (%) | 97.1 ± 7.5 | 98.8 ± 2.2 | 1.7 ± 7.9 | .4 | 2.8 | .2 |
| Average glucose, 24 h (mmol/L) | 9.9 ± 2.0 | 9.5 ± 1.1 | −0.4 ± 1.7 | .3 | −0.9 | .2 |
| Average glucose, night (mmol/L) | 9.5 ± 2.3 | 8.9 ± 1.2 | −0.7 ± 1.9 | .2 | −1.3 | .07 |
| Average glucose, day (mmol/L) | 10.1 ± 2.0 | 9.7 ± 1.1 | −0.4 ± 1.7 | .4 | −0.9 | .2 |
| Time in range (3.9‐10.0 mmol/L; %) | ||||||
| 24 h | 59.2 ± 22.3 | 64.3 ± 17.4 | 5.1 ± 16.0 | .2 | 11.7 | .1 |
| Night | 62.2 ± 28.8 | 69.5 ± 21.3 | 7.3 ± 21.3 | .2 | 14.7 | .08 |
| Day | 57.4 ± 20.5 | 61.4 ± 17.7 | 4.0 ± 17.3 | .4 | 10.2 | .2 |
| Glucose <3.9 mmol/L (% of time) | 0.9 ± 1.8 | 0.2 ± 0.6 | −0.6 ± 1.7 | .1 | −0.5 | .5 |
| Hypoglycaemic episodes (no.) b | 0.6 ± 1.2 | 0.3 ± 0.7 | −0.3 ± 0.9 | .2 | −0.04 | 1.0 |
| Glucose >10.0 mmol/L (% of time) | 40.0 ± 22.8 | 35.5 ± 17.4 | −4.5 ± 16.5 | .3 | −11.2 | .2 |
| Glucose >13.9 mmol/L (% of time) | 12.6 ± 17.6 | 7.0 ± 7.7 | −5.6 ± 15.5 | .2 | −8.6 | .1 |
| Glycaemic variability | ||||||
| CV, 24 h | 0.27 ± 0.06 | 0.25 ± 0.06 | −0.02 ± 0.04 | .1 | −0.02 | .6 |
| CV, night | 0.24 ± 0.08 | 0.22 ± 0.09 | −0.01 | .5 | −0.16 | .5 |
| CV, day | 0.26 ± 0.06 | 0.25 ± 0.06 | −0.02 | .1 | −0.01 | .5 |
CV, coefficient of variation.
a
In the between group difference column, the control group is reference.
b
Episode of hypoglycaemia is defined as glucose <3.9 mmol/L for more than 10 min.